| Crystal nucleation kinetics from induction times and metastable zone widths SA Kulkarni, SS Kadam, H Meekes, AI Stankiewicz, JH ter Horst Crystal growth & design 13 (6), 2435-2440, 2013 | 220 | 2013 |
| A new view on the metastable zone width during cooling crystallization SS Kadam, SA Kulkarni, RC Ribera, AI Stankiewicz, JH ter Horst, ... Chemical engineering science 72, 10-19, 2012 | 172 | 2012 |
| Isonicotinamide self-association: the link between solvent and polymorph nucleation SA Kulkarni, ES McGarrity, H Meekes, JH ter Horst Chemical communications 48 (41), 4983-4985, 2012 | 144 | 2012 |
| Template-induced nucleation of isonicotinamide polymorphs A Caridi, SA Kulkarni, G Di Profio, E Curcio, JH Ter Horst Crystal growth & design 14 (3), 1135-1141, 2014 | 46 | 2014 |
| Polymorphism control through a single nucleation event SA Kulkarni, H Meekes, JH Ter Horst Crystal growth & design 14 (3), 1493-1499, 2014 | 41 | 2014 |
| The use of cooling crystallization in an ionic liquid system for the purification of pharmaceuticals CC Weber, SA Kulkarni, AJ Kunov-Kruse, RD Rogers, AS Myerson Crystal Growth & Design 15 (10), 4946-4951, 2015 | 40 | 2015 |
| Self-association during heterogeneous nucleation onto well-defined templates SA Kulkarni, CC Weber, AS Myerson, JH Ter Horst Langmuir 30 (41), 12368-12375, 2014 | 36 | 2014 |
| Development of the Commercial Manufacturing Process for Nirmatrelvir in 17 Months C Allais, CG Connor, NM Do, S Kulkarni, JW Lee, T Lee, E McInturff, ... ACS Central Science 9 (5), 849-857, 2023 | 16 | 2023 |
| Understanding polymorph selection of sulfamerazine in solution C Liu, F Cao, SA Kulkarni, GPF Wood, EE Santiso Crystal Growth & Design 19 (12), 6925-6934, 2019 | 12 | 2019 |
| Early clinical development of lufotrelvir as a potential therapy for COVID-19 C Allais, D Bernhardson, AR Brown, GM Chinigo, JN Desrosiers, ... Organic process research & development 27 (12), 2223-2239, 2023 | 10 | 2023 |
| Cross-pharma collaboration for the development of a simulation tool for the model-based digital design of pharmaceutical crystallization processes (CrySiV) B Szilagyi, WL Wu, A Eren, J Mackey, S Kshirsagar, E Szilagyi, ... Crystal Growth & Design 21 (11), 6448-6464, 2021 | 9 | 2021 |
| Two-Stage Crystallizer Design for High Loading of Poorly Water-Soluble Pharmaceuticals in Porous Silica Matrices L Dwyer, S Kulkarni, L Ruelas, A Myerson Crystals 7 (5), 131, 2017 | 7 | 2017 |
| Methods for nano-crystals preparation SA Kulkarni, AS Myerson Engineering Crystallography: From Molecule to Crystal to Functional Form …, 2017 | 7 | 2017 |
| Reversible control of solubility using functionalized nanoparticles SA Kulkarni, AS Myerson Chemical communications 53 (8), 1429-1432, 2017 | 7 | 2017 |
| Synthesis of Nirmatrelvir: Design and Optimization of an Efficient Telescoped Amidation–Dehydration Sequence RF Algera, AF Baldwin, P Bowles, HJ Clarke, CG Connor, EM Cordi, ... Organic Process Research & Development 27 (12), 2250-2259, 2023 | 5 | 2023 |
| Methods for the purification of L-glufosinate SC Fields, MR Oberholzer, BM Green, S Kulkarni, J Nelson, P Andres US Patent 11,634,442, 2023 | 2 | 2023 |
| Streamlined Synthesis of a Bicyclic Amine Moiety Using an Enzymatic Amidation and Identification of a Novel Solid Form MS Brown, MA Caporello, AE Goetz, AM Johnson, KN Jones, KM Knopf, ... Organic Process Research & Development 25 (6), 1419-1430, 2021 | 2 | 2021 |
| Validation of the single nucleus mechanism by polymorphism S Kulkarni, SS Kadam, AI Stankiewicz, H Meekes, JH ter Horst BIWIC2011, 75-80, 2011 | 1 | 2011 |
| Compounds and methods for the treatment of COVID-19 RS Kania, P Bezawada, EL Hawking, R Jaini, S Kulkarni, MNOB Laramy, ... US Patent 11,926,642, 2024 | | 2024 |
| Methods for the purification of L-glufosinate SC Fields, MR Oberholzer, BM Green, S Kulkarni, J Nelson, P Andres US Patent 11,897,909, 2024 | | 2024 |
J.H. ter HorstKreberVerified email at Kreber.nl
